4035-18: Treatment Resistant Depression: Program Development for Ketamine Infusion

4.11 (9 votes)

4035-18: Treatment Resistant Depression: Program Development for Ketamine Infusion

Treatment resistant depression and acute suicidality may be effectively treated with serial ketamine infusions. The development of a ketamine infusion clinic is discussed and the role of nursing in assessing patients and managing infusions and aftercare of patients is reviewed. Lessons learned in the start-up of the clinic are explored.


Presenters:
  Courtney Miller, BSN, RN; Paula Bolton, MS, CNP, ANP-BC

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation.


Session Length:
  47 minutes

Target Audience:  RN, APRN


Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  • Describe the development of a ketamine infusion clinic and review criteria for ketamine treatment and the interdisciplinary nature of the treatment, including the role for PMH nurses in aiding recovery.

Keywords:  Ketamine Infusion, Treatment-Resistant Depression


Continuing Nursing Education:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Originally Presented
APNA 32nd Annual Conference
Columbus, Ohio
Saturday, October 27, 2018
12:15pm - 1:00pm

The contact hours for this session expire:  December 31, 2020

Components visible upon registration.